SEC Form 4 · accession 0001209191-17-056355
PORTOLA PHARMACEUTICALS INC · PTLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Henry Ward Wolff
Director
Period of report
Oct 5, 2017
Accepted (ET)
Oct 6, 2017 · 8:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001269021
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 5, 2017 | M | 12,000 | $5.30 | A | 12,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) | $5.30 | Oct 5, 2017 | M | 12,000 | D | Nov 15, 2007 | Nov 14, 2017 | Common Stock | 12,000 | 0 | D |